Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000315066-25-001413·FMR LLC
Schedule 13G ownership disclosure
Zenas Biopharma Inc
COMMON STOCK · CUSIP: 98937L105
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 2,852,371.00 · Class: 6.8%
- Abigail P. Johnson
Shares: 2,852,371.00 · Class: 6.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-25-001413
- Form type
- SCHEDULE 13G/A
- Filer
- FMR LLC
- CIK
- CIK 315066
- Filed
- May 12, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership